Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into a definitive agreement to acquire privately-held Tantti Laboratory Inc. (“Tantti”) of Taoyuan City, Taiwan. Tantti has developed a unique portfolio of macroporous chromatography beads to optimize the purification of new modalities including viral vectors, viruses, nucleic acids and other large molecule biologics.
Read the full article: Repligen Announces Agreement to Acquire Chromatography Innovator Tantti //
Source: https://www.globenewswire.com/news-release/2024/07/29/2920575/24603/en/Repligen-Announces-Agreement-to-Acquire-Chromatography-Innovator-Tantti.html